SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014705
Filing Date
2023-08-14
Accepted
2023-08-14 07:36:41
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20230630x10q.htm   iXBRL 10-Q 1106487
2 EX-10.1 zyne-20230630xex10d1.htm EX-10.1 121592
3 EX-10.2 zyne-20230630xex10d2.htm EX-10.2 39359
4 EX-10.3 zyne-20230630xex10d3.htm EX-10.3 38997
5 EX-10.4 zyne-20230630xex10d4.htm EX-10.4 29963
6 EX-10.5 zyne-20230630xex10d5.htm EX-10.5 28959
7 EX-10.6 zyne-20230630xex10d6.htm EX-10.6 24547
8 EX-31.1 zyne-20230630xex31d1.htm EX-31.1 11479
9 EX-31.2 zyne-20230630xex31d2.htm EX-31.2 11212
10 EX-32.1 zyne-20230630xex32d1.htm EX-32.1 6121
11 EX-32.2 zyne-20230630xex32d2.htm EX-32.2 6146
12 GRAPHIC zyne-20230630x10q001.jpg GRAPHIC 51931
13 GRAPHIC zyne-20230630xex10d1001.jpg GRAPHIC 939
14 GRAPHIC zyne-20230630xex10d1002.jpg GRAPHIC 831
15 GRAPHIC zyne-20230630xex10d3001.jpg GRAPHIC 939
16 GRAPHIC zyne-20230630xex10d3002.jpg GRAPHIC 831
  Complete submission text file 0001558370-23-014705.txt   5457848

Data Files

Seq Description Document Type Size
17 EX-101.SCH zyne-20230630.xsd EX-101.SCH 38342
18 EX-101.CAL zyne-20230630_cal.xml EX-101.CAL 37578
19 EX-101.DEF zyne-20230630_def.xml EX-101.DEF 143284
20 EX-101.LAB zyne-20230630_lab.xml EX-101.LAB 298336
21 EX-101.PRE zyne-20230630_pre.xml EX-101.PRE 247319
65 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20230630x10q_htm.xml XML 881748
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 231166296
SIC: 2834 Pharmaceutical Preparations